Bioresorbable Polymers Market Research Report - Global Forecast till 2030

Bioresorbable Polymers Market Research Report: Information by Type (Agro-Polymers [Proteins and Polysaccharides] and Bio-polyesters [Polyglycolic Acid, Polylactic Acid, Polycaprolactone, Polydioxanone, and others]), Application (Orthopedics, Drug Delivery, and Others) and Region (Asia-Pacific, North America, Europe, Latin America, and Middle East & Africa) - Forecast till 2030

ID: MRFR/CnM/0463-HCR | October 2022 | Region: Global | 185 Pages         

Bioresorbable Polymers Market Speak to Analyst Request a Free Sample

Bioresorbable Polymers Market Overview

The Bioresorbable Polymers Market Value is projected to reach USD 3.15 billion by 2028, and a growth rate or CAGR of 14.1 % during the forecast period by 2030. In the last year, the market secured a value of USD 1.43 billion in 2021.

Bioresorbable polymers are known as biodegradable or bioresorbable polymer materials that can be safely absorbed into the body and used in the healthcare sector. These polymers can decompose easily through the hydrolysis process. Due to its safety measures towards the body and environment, the
Bioresorbable Polymers Market is growing higher in demand.

The most used bioresorbable polymers are polyglycolic acid, polylactic acid, and polycaprolactone. It has shown huge application in orthopaedics, surgical implants, drug delivery, and other healthcare uses. These factors are boosting the Bioresorbable Polymers Market Size.

The healthcare industry is the key driver of the market due to its higher consumption of bioresorbable polymers. These polymers are preferred for several implants rather than other conventional methods, driving the Market Growth. Moreover, the rise in the number of orthopaedics cases has become a common health problem globally which is propelling the market’s demand.

The increased rate of the senior population above the 55 age group is thriving towards the growth of the Bioresorbable Polymers Market.

With the help of bioresorbable polymers, implants are made. It even eliminates the need for a second surgery and prevents other risks related to the second surgery. This factor has led to the demand for bioresorbable polymers in implant surgery without a second thought. These polymers are chiefly adopted for developing convenient and efficient drug delivery systems. Due to all these growth influencing factors, the Market is growing at a higherpace.

COVID-19 Analysis

During the pandemic period, the Bioresorbable Polymers Market was badly affected due to the shutdown of industrial units. The manufacturing units remained closed for more than a year, which decreased the market’s demand and resulted in a huge economic loss. The supply of raw materials was restricted, and delivery of the products to the destination was also delayed.

But later, the Bioresorbable Polymers Market recovered from the loss when its demand was propelled in health industries. The medicals sectors remained open throughout the pandemic, which has driven the market globally.

Chief Factors Existing In The Market

Key Market Drivers

The growth drivers of the Bioresorbable Polymers Market are highly focused by the manufacturers to plan strategies accordingly. The driving factors accelerate the market’s global performance. Their presence secures the future market’s growth. The growth of the biomedical sector is one of the major drivers of the market. The higher adoption of these polymers in healthcare industries for surgical implants is another major driving factor.

Market Challenges

The Bioresorbable Polymers Market faces challenges that are hampering the market’s growth progress. Factors such as lack of awareness and experts in this field are highly challenging to the market. The pandemic hit was another challenge which is in the process to recover sooner.

Market Opportunities

The rising opportunities of the Bioresorbable Polymers Market are letting the market enhance globally. The heavy investments in research and development activities by the government and the end-users bring huge opportunities for the market. The bioresorbable polymers are in the process to become cost-effective and high quality. These factors will propel the market’s demand. Innovative techniques like electrospinning and 3D printing are helping the Market to elevate with opportunity.

Market Restraints

The restraining or constraining factors of the Bioresorbable Polymers Market are hindering its growth rate. The higher cost price for bioresorbable polymers is a major restraint. Lack of quality control of bioresorbable polymers, which is making them risky for implants and surgeries, is another restraining factor. 

Cumulative Evaluation Of The Market

The cumulative evaluation of the Bioresorbable Polymers Market shows that it will reach a good CAGR and significant value in the forecast period. The market dynamics show their effects, which directly impact the market’s growth rate. The growth-enhancing factors such as the drivers and opportunities accelerate the Bioresorbable Polymers Market Value. 

Market Segmentation

The Bioresorbable Polymers Market is segmented into type and application.

By Type

The type section of the market is categorized into agro-polymers and bio-polyesters. The agro-polymers are further sub-categorized into proteins and polysaccharides. The bio-polyesters segment consists of polylactic acid, polyglycolic acid, polydioxanone, polycaprolactone, and others. The bio-polyesters segment is expected to acquire substantial growth in the forecast period because of its enhanced quality and resistance to bad environmental conditions.

By Application

The application segment of the Bioresorbable Polymers Market is fragmented into orthopaedics, drug delivery and others.

The orthopaedic segment will be the dominating segment with a significant growth rate in the forecast period due to the number of orthopaedic patients. The rise in the geriatric population is another factor driving the market.  

Global Bioresorbable Polymers Market Share, by Region, 2018 (%)  Bioresorbable Polymers Market

Source: MRFR Analysis

Regional Analysis

The Bioresorbable Polymers Market shows its regional distribution in prominent regions such as North America, Europe, Latin America, Asia Pacific and the Middle East and Africa.

North America is considered the leading region. It accounts for the largest market share in recent years due to the increased demand for these polymers in biomedical industries driving the regional market. The US and Canada are the major regions of North America which are attributed to the market’s growth due to the presence of key industrial players. The rise in innovations and advanced technologies to improve novel biocompatible polymers for widening their physical and degradation characteristics is accelerating its regional market. 

Asia-Pacific has secured substantial growth, and it will acquire the highest CAGR during the forecast period. The increase in demand for bioresorbable polymers in healthcare industries in various developing countries is driving the APAC market. The rise in consumer awareness in the region is expected to drive the market demand. China is the leading region, followed by India and Southeast Asian countries. These regions are showing a higher growth rate due to the increased rate of the medical and hospital industry.

The Bioresorbable Polymers Market in Europe is showing significant growth because of the higher usage of bioresorbable polymers in orthopaedics and drug delivery applications. Germany is considered the major contributor due to the presence of leading players.

Other regions of the world, such as Latin America and the Middle East & Africa, will show a steady growth rate in the forecast period due to the increased awareness among consumers and tremendous growth of healthcare industries.

Competitive Intensity Within The Industry 

The industrial players take the responsibility to emerge the Bioresorbable Polymers Market Trends to propel its growth rate. The players monitor the company overview, valuation, annual revenue and others factors to monitor its smooth function. All the industrial activities will eventually drive the market’s performance. The players predict the sales rate and its further growth to maintain the market standard and business growth. The presence of players in prominent regions worldwide promotes regional market growth. The market players are concerned about the current trends and focus on developmental activities like launching products, collaboration, partnerships, mergers and acquisitions to drive the Bioresorbable Polymers Market Growth. Here is the list of prominent industrial players.


  • Merck KGaA (Germany)

  • Koninklijke DSM N.V (The Netherlands)

  • KLS Martin (US)

  • Corbion NV (The Netherlands)

  • Evonik Industries AG (Germany)

  • Foster Corporation. (US)

  • Poly-Med Inc. (US)

  • Ashland (US)

  • Putnam Plastics (US) 

  • Groupe PCAS (France)

  • REVA Medical, Inc.(US).

Recent Market Developments

February 2021- a Houston-based advanced materials company, VenoStent, announced USD 2.3M in seed funding. The firm uses its unique polymer engineering technology to build bioresorbable slip-on polymer wraps, known as SelfWrap. The product’s goal is to eradicate vascular surgery failures, at first aiming vascular access surgery needed to start hemodialysis treatment for end-stage renal disease (ESRD) patients.
Creative Ventures guided the round with involvement from IAG Capital Partners, Cowtown Angels, Texas Halo Fund, Olima Ventures, C3 Ventures, and SP Investment Fund, among numerous other prominent investors, following their participation in Y Combinator’s Summer 2020 Batch.

August 2021- Ashland finished expanding the company’s Viatel bioresorbable polymer production site and moved research and development (R&D) to the National Science Park, Mullingar, Ireland, from Dublin. The National Science Park in Mullingar has been a native place for a network of innovative organizations, including Ireland’s leading research center for producing solutions (IMR).
The business manager at Viatel bioresorbable polymers, Ashland, Seán McMahon, said that Viatel bioresorbable polymers are utilized to offer enhanced treatment solutions for several chronic diseases. He added that These materials act as the building blocks in further release drug formulations, tissue engineering scaffolds, and bioresorbable medical devices. Moving the R&D center to the Mullingar site is an important step for the company’s new product development strategy and capacity to solve complicated customer challenges with personalized chemistry.

Report Overview

The report overview of the Bioresorbable Polymers Market Analysis states the growth accelerating factors and even the restricting features. The report covers the complete market dynamics, such as the drivers, opportunities, challenges and restraints. The pandemic report was discussed in detail, including the loss and recovery. The segmentation analysis showcased the prominent segments and their growth estimation. Geographical data of the market covered the regions noticing higher regional growth and their influencing factors. The key player and their competitive intensity, along with their developmental activities, were mentioned in detail. Hence, the Bioresorbable Polymers Market Outlook will reach the estimated growth value in the review period.

Key Industrial Segments

By Type

  • Agro-polymers

  • Bio-polyesters

By Application

  • Orthopedics

  • Drug Delivery 

  • Others

Report Scope:

Report Attribute/Metric Details
  Market Size

  • 2021: USD 1.43 Billion
  • 2030: USD 3.15 Billion
  •   CAGR   14.1%(2021–2030)
      Base Year   2019
      Forecast Period   2020-2030
      Historical Data   2018
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   By Type, Application and Region
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Corbion NV (The Netherlands), Evonik Industries AG (Germany), Foster Corporation.(US), Poly-Med Inc. (US), DURECT CORPORATION (US), Merck KGaA (Germany), Koninklijke DSM N.V (The Netherlands), KLS Martin (US), Ashland (US), Putnam Plastics (US) and Groupe PCAS (France), REVA Medical, Inc.(US).
      Key Market Opportunities   The increasing use of bioresorbable polymers as scaffolds for cells in tissue engineering, sutures, biodegradable stents, tissue fixation
      Key Market Drivers   Drive the global market in biomedical sector.

    Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The global bioresorbable polymers market is predicted to touch USD 3.15 billion by 2028.

    The bioresorbable polymers market is predicted to grow at a 14.1% CAGR between 2021-2028.

    North America is predicted to lead the bioresorbable polymers market during the forecast period.

    Key competitors in the bioresorbable polymers market include REVA Medical, Inc. (US), Groupe PCAS (France), Putnam Plastics (US), Ashland (US), KLS Martin (US), Koninklijke DSM N.V (The Netherlands), Merck KGaA (Germany), DURECT CORPORATION (US), Poly-Med Inc. (US), Foster Corporation.(US), Evonik Industries AG (Germany), and Corbion NV (The Netherlands).

    Growing healthcare sector, increasing use in the controlled drug delivery matrix, and growing accident rate are boosting the market growth.

    Global Bioresorbable Polymers Market: Competitive Landscape

    Majors players covered in the global bioresorbable polymers market report are KLS Martin Group, Poly-Med, Inc., DURECT Corporation, Corbion NV, Evonik Industries AG, Foster Corporation, PCAS Group, Merck KGaA, and Royal DSM NV.

    Among the aforementioned companies, the top five players namely Corbion NV, Evonik Industries AG, Foster Corporation, Merck KGaA, and Royal DSM NV are collectively dominating the global market. Some of the major industry players are adopting collective approaches to hold the major share of this market. Moreover, key operating producers have adopted various strategies such as capacity expansion, patent filing, acquisition, and product launch as their major business tactics.

    Corbion NV develops, manufactures, sale, and distributes ingredients in food and biochemical. The company operates through two business segment namely food and biochemical. The food segment offers bio-based ingredients to the food industry. Corbion strategy is to create sustainable growth in the food and biochemical. The company is building new business platforms in biotechnology based on their fermentation expertise. In November 2016, Total and Corbion established a joint venture to manufacture and sell polylactic (PLA) polymers. The company was planned to construct a PLA polymerization plant with an annual capacity of 75,000 tons at Corbion’s site in Thailand.

    Evonik Industries AG, a leading chemical company, is involved in the specialty chemicals business across the globe. The company operates through four business segments namely nutrition & care, resource efficiency, performance materials, and services. The company has its presence in Western Europe, Eastern Europe, North America, Central and South America, Asia Pacific, and the Middle East & Africa. Evonik Industries launched a new range of RESOMER composites to increase the performance of bone fixation device. This product launch would help the company to strengthen their position among the Bioresorbable polymer manufacturers.

    Foster Corporation is involved in developing and manufacturing biomedical polymers for the medical device industry. The company contributes and sells medical grade Pebax MED block co-polyamides and medical grade Rilsan MED polyamides for the medical market. Foster Corporation has a manufacturing unit in Las Vegas, Putnam CT, and Nevada.  Foster Corporation operates as a subsidiary of PolyMedex Discovery Group, Inc. In February 2017, Foster Corporation and ProMed Pharma established an agreement to offer contract services for pharmaceutical and combination device applications. This agreement would help the company to increase the marketing, business development, and technical services for a broad range of drug delivery materials and processing technologies.

    Merck KGaA is involved in the manufacturing of chemical products and pharmaceutical. The company operates through three business segment namely healthcare, life science, and performance materials. The company manufactures medical devices under the healthcare business segment. The company has a strong presence in Europe, North America, and Asia Pacific. In July 2016, Merck kGaA and PCAS signed an agreement to expand Merck’s excipients portfolio. Under this agreement, Merck will distribute the Expansion line of biocompatible and biodegradable polymers across the globe. The product portfolio comprises polymers for small molecules and peptide injectables.

    Royal DSM NV is involved in the manufacturing and sales of nutritional, pharmaceutical ingredients, and industrial chemicals. The company operates through four business segments namely nutrition, materials, innovation center, and corporate activities. The company has a significant presence across the globe and is a key manufacturer of bioresorbable polymers.